Anne Vanlent, Director at Biota Pharmaceuticals, Inc. (BOTA), bought 35,000 shares at $2.20 ($77K) on 2015-06-22, disclosed to the SEC on 2015-06-24.
Open-market purchase of $77k BOTA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| IART | SELL | 2011-01-14 | $250K | — | Filing → |
| PPCO | SELL | 2008-11-10 | $7K | — | Filing → |